DLA PIPER LLP (US) for NOVARTIS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| VINCENT SARUBBI | — |
| MICHAEL SORENSEN | — |
Taxation/Internal Revenue Code TAX
Tax reform and tax policy.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| VINCENT SARUBBI | — |
| MICHAEL SORENSEN | — |
Trade (domestic/foreign) TRD
Tariffs.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| VINCENT SARUBBI | — |
| MICHAEL SORENSEN | — |
Health Issues HCR
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| VINCENT SARUBBI | — |
| MICHAEL SORENSEN | — |
Medicare/Medicaid MMM
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| VINCENT SARUBBI | — |
| MICHAEL SORENSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.